IL6 and cancer: The mechanism is promoted by an S1P/S1P1-dependent increase in signal transducer and activator of transcription 3 (STAT3) and IL-6 formation; this S1P1 dependent pro-inflammatory pathway was first, demonstrated in cancer cells [58].